Acne Vaccine: The Science, the Trials and When It Could Arrive
An acne jab sounds unlikely — but Sanofi is already testing one in people. Here is the science behind it, the trials under way, and why it is still years from the pharmacy.
- Written by
- Health Daily Advice
- Published
- Reading time
- 5 minutes
- Sources
- 4 cited
In this guide
Scientists are testing vaccines that could one day treat acne by calming the immune system’s reaction to a skin bacterium, Cutibacterium acnes, instead of killing the bacterium itself. Drugmaker Sanofi has started early human trials of an mRNA vaccine in adults aged 18 to 45. No acne vaccine is approved yet, and any licensed jab is still years away.
What is acne, and why would a vaccine help?
Acne is an inflammatory disorder of the hair follicles and the oil glands attached to them. Hormones increase oil production, dead skin cells block the pore, and C. acnes — a bacterium that normally lives harmlessly on healthy skin — thrives in the trapped oil and releases substances that trigger inflammation. The result is blackheads, whiteheads, papules, pustules, nodules and cysts, most often on the face, back and chest.
It is extraordinarily common: acne affects around 85% of adolescents, according to the American Academy of Dermatology, and about 95% of people aged 11 to 30 are affected to some extent, according to the NHS. For some it is a few spots; for others it means years of painful inflammation, scarring and lost confidence. Current treatments control acne rather than prevent it: creams and gels, antibiotics, and, for severe cases, oral isotretinoin. Antibiotics can drive resistance and disturb the gut microbiome, isotretinoin needs regular monitoring, and most treatments must be used daily. A vaccine that offered lasting control could change that — and cut antibiotic use, which matters in the fight against antibiotic resistance.
How would an acne vaccine work?
The new approach does not try to wipe out C. acnes. Different strains of the bacterium produce different proteins, and the strains linked to acne make higher levels of proteins that drive inflammation. The vaccines aim to disarm those specific proteins:
- CAMP2 — a bacterial protein involved in inflammation. A 2018 study targeting CAMP2 reported reduced inflammation in mice and in human acne tissue studied outside the body.
- HylA — an enzyme produced by acne-associated strains of C. acnes. A 2023 study found that a vaccine targeting HylA reduced acne-like inflammation in mice.
Sanofi’s candidate uses mRNA technology: it gives the body temporary instructions to make selected proteins, which the immune system learns to recognise and then neutralise — the same principle behind mRNA Covid vaccines. The hope is that neutralising these proteins will mean fewer and less inflamed lesions, while leaving the helpful bacteria on the skin alone. As one researcher involved in the trials put it, the goal is to restore a healthy skin microbiome balance and reduce the need for repeated courses of antibiotics.
The Sanofi trials: what is happening now
Sanofi is investigating an mRNA vaccine targeting CAMP2, and currently has two phase 1 and 2 studies recruiting adults aged 18 to 45. One plans to enrol 800 people with moderate-to-severe acne, testing different doses and two- or three-injection schedules. The other is seeking 228 participants with mild acne, who would receive two injections. The trials are running at sites in the United States, Canada, Australia and Singapore, and are designed to assess safety, the immune response produced, and whether acne improves.
One detail matters: the participants already have acne, so the trials are testing the vaccines as a treatment, not as a way of preventing acne before it starts. Sanofi is not the only company in the race. US start-up Armora Biosciences is developing a vaccine against HylA, based on work by Professor George Liu at the University of California, San Diego — the team that identified the enzyme.

What still has to be proved
The road from promising lab results to a licensed vaccine is long, and the researchers are open about the gaps:
- Does it work in people? Reduced inflammation in mice and in tissue studied outside the body does not prove a vaccine clears acne in humans.
- Is it safe long-term? Short- and long-term safety, how long any benefit lasts, and whether boosters are needed are all unknown.
- Does it protect the skin’s microbiome? Trial participants’ skin microbiomes are being monitored to check that helpful bacteria are preserved.
- Who could it help? Whether it is safe and effective for children and adolescents, or can prevent acne before it develops, will need separate studies designed for those questions.
- Would people take it? Vaccine hesitancy, cost and uncertainty could all affect uptake, even if the science works.
When could an acne vaccine arrive?
Not soon. The current trials are early phase 1 and 2 studies, which mainly assess safety and immune responses. A successful candidate would still need larger phase 2 and 3 trials before regulators could approve it — a process that can take several years. As researchers quoted by Gavi note, regulators, clinicians and patients will also have to weigh the benefits of preventing a condition that is rarely life-threatening against the risks of vaccinating against it. If acne vaccines do succeed, they could mark the start of a new class of vaccines aimed not just at stopping infections, but at recalibrating the relationship between microbes, the immune system and chronic conditions.
What to do about acne now
Do not wait for a vaccine that could be some years away. Effective treatments already exist. For mild acne, a pharmacist can advise on creams, lotions and gels — products containing a low concentration of benzoyl peroxide are often recommended, though they can bleach clothing. The NHS advises washing affected areas no more than twice a day with a mild soap or cleanser and lukewarm water, not squeezing spots (which can cause permanent scarring), and using water-based, non-comedogenic make-up and skincare. Treatments can take several months to work, so do not expect results overnight.
When to see a doctor
See a GP if your acne is moderate or severe, if you develop nodules or cysts, if pharmacy treatments have not controlled it, or if it is making you feel very unhappy — acne can affect mental health, and that is a proper reason to seek help. A GP can explain prescription options and refer you to a dermatologist if needed. In an emergency call 911 (US), 999 (UK) or 112 (EU).
Frequently asked questions
Is there an acne vaccine yet?
No. No acne vaccine is licensed or approved anywhere. Sanofi's mRNA vaccine is in early phase 1 and 2 trials in adults in several countries, and other candidates are still in laboratory research. A licensed vaccine, if one succeeds, is years away.
How does an acne vaccine work?
It trains the immune system to recognise and neutralise inflammatory proteins — CAMP2 and HylA — made by acne-linked strains of the skin bacterium Cutibacterium acnes. The aim is to calm the inflammation that causes spots, without killing the bacterium, which normally lives harmlessly on healthy skin.
Who is in the acne vaccine trials?
Adults aged 18 to 45 who already have acne. One Sanofi trial plans to enrol 800 people with moderate-to-severe acne; the other seeks 228 people with mild acne. The trials run at sites in the United States, Canada, Australia and Singapore.
Would an acne vaccine prevent acne or treat it?
The current trials test the vaccines as a treatment in people who already have acne, not as prevention. Whether a vaccine could prevent acne before it starts, or work safely in children and teenagers, would need separate studies designed for those questions.
When will an acne vaccine be available?
Not soon. The current studies are early phase 1 and 2 trials that mainly assess safety and immune response. A successful candidate would still need larger phase 2 and 3 trials and regulatory approval, a process that can take several years.
What should I do about acne now?
Do not wait for a vaccine. A pharmacist can advise on creams and gels for mild acne, and a GP can explain prescription options and refer you to a dermatologist if acne is moderate or severe, causes nodules or cysts, risks scarring, or is affecting how you feel.
Sources
- The Conversation via Medical Xpress: A vaccine for acne? Scientists are working on it medicalxpress.com
- Gavi: Could acne be prevented with a vaccine? www.Gavi.org
- NHS: Acne healthwell.eani.org.uk
- The Independent: What to know about the acne vaccine trial indy-web-prod.brightsites.co.uk
Try the tool
Not sure if it can wait?
Common causes and warning signs for 16 everyday symptoms.
Open the symptom guide

